WO2008056139A3 - Transdermal therapy - Google Patents
Transdermal therapy Download PDFInfo
- Publication number
- WO2008056139A3 WO2008056139A3 PCT/GB2007/004245 GB2007004245W WO2008056139A3 WO 2008056139 A3 WO2008056139 A3 WO 2008056139A3 GB 2007004245 W GB2007004245 W GB 2007004245W WO 2008056139 A3 WO2008056139 A3 WO 2008056139A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- transdermal therapy
- zolpidem
- transdermal
- therapy
- caffeine
- Prior art date
Links
- 238000002560 therapeutic procedure Methods 0.000 title 1
- RYYVLZVUVIJVGH-UHFFFAOYSA-N caffeine Chemical compound CN1C(=O)N(C)C(=O)C2=C1N=CN2C RYYVLZVUVIJVGH-UHFFFAOYSA-N 0.000 abstract 2
- ZAFYATHCZYHLPB-UHFFFAOYSA-N zolpidem Chemical compound N1=C2C=CC(C)=CN2C(CC(=O)N(C)C)=C1C1=CC=C(C)C=C1 ZAFYATHCZYHLPB-UHFFFAOYSA-N 0.000 abstract 2
- 229960001475 zolpidem Drugs 0.000 abstract 2
- LPHGQDQBBGAPDZ-UHFFFAOYSA-N Isocaffeine Natural products CN1C(=O)N(C)C(=O)C2=C1N(C)C=N2 LPHGQDQBBGAPDZ-UHFFFAOYSA-N 0.000 abstract 1
- 229960001948 caffeine Drugs 0.000 abstract 1
- VJEONQKOZGKCAK-UHFFFAOYSA-N caffeine Natural products CN1C(=O)N(C)C(=O)C2=C1C=CN2C VJEONQKOZGKCAK-UHFFFAOYSA-N 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
- A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
- A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
- A61K9/7084—Transdermal patches having a drug layer or reservoir, and one or more separate drug-free skin-adhesive layers, e.g. between drug reservoir and skin, or surrounding the drug reservoir; Liquid-filled reservoir patches
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
- A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
Landscapes
- Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Dermatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Abstract
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB0622285A GB0622285D0 (en) | 2006-11-08 | 2006-11-08 | Transdermal therapy |
GB0622285.5 | 2006-11-08 | ||
GB0705689.8 | 2007-03-21 | ||
GB0705689A GB0705689D0 (en) | 2007-03-21 | 2007-03-21 | Therapeutic applications of Zolpidem |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2008056139A2 WO2008056139A2 (en) | 2008-05-15 |
WO2008056139A3 true WO2008056139A3 (en) | 2008-10-02 |
Family
ID=38858432
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/GB2007/004245 WO2008056139A2 (en) | 2006-11-08 | 2007-11-08 | Transdermal therapy |
Country Status (2)
Country | Link |
---|---|
GB (1) | GB2443928A (en) |
WO (1) | WO2008056139A2 (en) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB0809936D0 (en) * | 2008-05-30 | 2008-07-09 | Regen Therapeutics Plc | Therapeutic use of zolpidem |
Citations (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2000033835A1 (en) * | 1998-12-04 | 2000-06-15 | Sanofi-Synthelabo | Controlled-release dosage forms comprising zolpidem or a salt thereof |
EP1201230A2 (en) * | 2000-10-27 | 2002-05-02 | BioChemics, Inc. | Solution-based transdermal drug delivery system comprising a vasodilator |
US6638528B1 (en) * | 2000-01-20 | 2003-10-28 | Noven Pharmaceuticals, Inc. | Compositions and methods to effect the release profile in the transdermal administration of active agents |
US20040220262A1 (en) * | 1999-12-16 | 2004-11-04 | Tsung-Min Hsu | Transdermal and topical administration of drugs using basic permeation enhancers |
US20040265239A1 (en) * | 1997-10-01 | 2004-12-30 | Novadel Pharma Inc. | Buccal, polar and non-polar spray containing zolpidem |
WO2005060945A2 (en) * | 2003-12-24 | 2005-07-07 | Archimedes Development Limited | Intranasal compositions comprising zolpidem |
US20050150190A1 (en) * | 2000-03-14 | 2005-07-14 | Noven Pharmaceuticals, Inc. | Packaging meterials for transdermal drug delivery systems |
US20060078604A1 (en) * | 2004-10-08 | 2006-04-13 | Noven Pharmaceuticals, Inc. | Transdermal drug delivery device including an occlusive backing |
US20060078603A1 (en) * | 2004-10-08 | 2006-04-13 | Noven Pharmaceuticals, Inc. | Transdermal delivery of drugs based on crystal size |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1991003998A1 (en) * | 1989-09-14 | 1991-04-04 | Cygnus Research Corporation | Transdermal delivery device having delayed onset |
IT1276522B1 (en) * | 1995-04-07 | 1997-10-31 | Elena Benincasa | USE OF ZOLPIDEM FOR THE THERAPEUDIC TREATMENT OF NEUROPSYCHIATRIC SYNDROMES ASSOCIATED WITH DYSFUNSION AND NEURAL CIRCUITS OF |
US20040204443A1 (en) * | 2003-01-27 | 2004-10-14 | Arthur Zaks | Method for inducing pain relief using imidazo[1,2-a]pyridine derivatives |
EP1624867A1 (en) * | 2003-05-19 | 2006-02-15 | Sciencom Ltd | Further therapeutic use of zolpidem |
-
2007
- 2007-11-08 GB GB0722015A patent/GB2443928A/en not_active Withdrawn
- 2007-11-08 WO PCT/GB2007/004245 patent/WO2008056139A2/en active Application Filing
Patent Citations (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20040265239A1 (en) * | 1997-10-01 | 2004-12-30 | Novadel Pharma Inc. | Buccal, polar and non-polar spray containing zolpidem |
WO2000033835A1 (en) * | 1998-12-04 | 2000-06-15 | Sanofi-Synthelabo | Controlled-release dosage forms comprising zolpidem or a salt thereof |
US20040220262A1 (en) * | 1999-12-16 | 2004-11-04 | Tsung-Min Hsu | Transdermal and topical administration of drugs using basic permeation enhancers |
US6638528B1 (en) * | 2000-01-20 | 2003-10-28 | Noven Pharmaceuticals, Inc. | Compositions and methods to effect the release profile in the transdermal administration of active agents |
US20050150190A1 (en) * | 2000-03-14 | 2005-07-14 | Noven Pharmaceuticals, Inc. | Packaging meterials for transdermal drug delivery systems |
EP1201230A2 (en) * | 2000-10-27 | 2002-05-02 | BioChemics, Inc. | Solution-based transdermal drug delivery system comprising a vasodilator |
WO2005060945A2 (en) * | 2003-12-24 | 2005-07-07 | Archimedes Development Limited | Intranasal compositions comprising zolpidem |
US20060078604A1 (en) * | 2004-10-08 | 2006-04-13 | Noven Pharmaceuticals, Inc. | Transdermal drug delivery device including an occlusive backing |
US20060078603A1 (en) * | 2004-10-08 | 2006-04-13 | Noven Pharmaceuticals, Inc. | Transdermal delivery of drugs based on crystal size |
Also Published As
Publication number | Publication date |
---|---|
WO2008056139A2 (en) | 2008-05-15 |
GB0722015D0 (en) | 2007-12-19 |
GB2443928A (en) | 2008-05-21 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL283205A (en) | Cell binding agent drug conjugates, compositions comprising the same and uses thereof | |
IL206395A (en) | N-heterocyclyl-7-oxo-6-sulfooxy-1,6-diazabicyclo[3.2.1]octane-2-carboxamides and pharmaceutical compositions comprising them | |
WO2007109812A3 (en) | Immunopotentiating compounds | |
IL193240A0 (en) | Dihydrodiazepine derivatives and pharmaceutical compositions containing the same | |
EP1909772A4 (en) | Transdermal drug delivery formulation | |
IL191902A0 (en) | Azaindole derivatives and pharmaceutical compositions containing the same | |
EP2143713A4 (en) | Novel pyrrolinone derivative and medicinal composition containing the same | |
IL198509A0 (en) | Azaindole derivatives, compositions containing the same and uses thereof | |
IL221952A (en) | 2,3-dihydro-1h-inden-1-yl-2,7- diazaspiro[3.5] nonane derivatives and pharmaceutical compositions comprising the same | |
TWI350756B (en) | 8-[3-amino-piperidin-1-yl]-xanthines, their preparation and their use as pharmaceutical compositions | |
IL186458A0 (en) | Skin enrichment using coq10 as the delivery system | |
IL196033A0 (en) | Pyrrolotriazine derivatives and pharmaceutical compositions containing the same | |
IL198591A0 (en) | Combination therapy with sglt-2 inhibitors and their pharmaceutical compositions | |
IL213365A (en) | Imidazopyrazine and pharmaceutical compositions comprising the same | |
IL206808A (en) | Indolyl-pyridone derivatives, pharmaceutical compositions comprising the same and uses thereof | |
IL204844A (en) | Quinolone analogs, pharmaceutical compositions comprising the same and uses thereof | |
IL193772A0 (en) | 4-oxoquinoline derivatives,methods for the preparation thereof and pharmaceutical compositions containing the same | |
PL2083809T3 (en) | Dietary or pharmaceutical compositions containing tricyclic diterpenes for the treatment of depression. | |
WO2007084857A3 (en) | Methods and compositions for treating cell proliferative disorders | |
GB0614586D0 (en) | Pharmaceutical Formulation | |
WO2010021607A3 (en) | Pharmaceutical formulation | |
IL210316A (en) | Triazole derivatives, pharmaceutical compositions comprising the same and uses thereof | |
EP2073825A4 (en) | Cinnamomi and poria composition and uses thereof | |
HK1200446A1 (en) | Piperidine compounds, pharmaceutical composition comprising the same and its use | |
WO2010046061A3 (en) | Cosmetic and/or pharmaceutical formulations |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 07824478 Country of ref document: EP Kind code of ref document: A2 |
|
ENP | Entry into the national phase |
Ref document number: 2009535794 Country of ref document: JP Kind code of ref document: A |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
NENP | Non-entry into the national phase |
Ref country code: JP |
|
122 | Ep: pct application non-entry in european phase |
Ref document number: 07824478 Country of ref document: EP Kind code of ref document: A2 |